Conmed Stock Today
| CNMD Stock | USD 63.15 1.22 1.90% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
CONMED is trading at 63.15 as of the 16th of February 2025, a 1.9% down since the beginning of the trading day. The stock's lowest day price was 62.46. CONMED has only four percent chance of going through some form of financial distress over the next 2 years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 16th of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 23rd of July 1987 | Category Healthcare | Classification Health Care |
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. C O operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 30.89 M outstanding shares of which 846.97 K shares are currently shorted by private and institutional investors with about 6.57 trading days to cover. More on CONMED
Moving together with CONMED Stock
| 0.78 | COO | Cooper Companies, Downward Rally | PairCorr |
Moving against CONMED Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
CONMED Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Curt Hartman | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Cannomed Medical Cannabis Industries Ltd | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCONMED can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CONMED's financial leverage. It provides some insight into what part of CONMED's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CONMED (CNMD) is traded on New York Stock Exchange in USA. It is located in 11311 Concept Boulevard, Largo, FL, United States, 33773-4908 and employs 4,000 people. CONMED is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.95 B. CONMED conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 30.89 M outstanding shares of which 846.97 K shares are currently shorted by private and institutional investors with about 6.57 trading days to cover.
CONMED currently holds about 33.35 M in cash with 125.35 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.09.
Check CONMED Probability Of Bankruptcy
Ownership AllocationCONMED holds a total of 30.89 Million outstanding shares. The majority of CONMED outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CONMED to benefit from reduced commissions. Thus, institutional investors are subject to a different set of regulations than regular investors in CONMED. Please pay attention to any change in the institutional holdings of CONMED as this could imply that something significant has changed or is about to change at the company. Also note that nearly two hundred sixty-eight thousand seven hundred fifty-one invesors are currently shorting CONMED expressing very little confidence in its future performance.
Check CONMED Ownership Details
CONMED Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 718.3 K | |
| Geode Capital Management, Llc | 2024-09-30 | 693.4 K | |
| Cooke & Bieler Lp | 2024-12-31 | 664 K | |
| Principal Financial Group Inc | 2024-12-31 | 625.1 K | |
| Deerfield Management Co | 2024-09-30 | 614.9 K | |
| Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 501.8 K | |
| Clearbridge Advisors, Llc | 2024-09-30 | 496.4 K | |
| Fisher Asset Management, Llc | 2024-12-31 | 417.4 K | |
| Wells Fargo & Co | 2024-09-30 | 413.8 K | |
| Blackrock Inc | 2024-09-30 | 5 M | |
| Vanguard Group Inc | 2024-09-30 | 3.5 M |
CONMED Historical Income Statement
CONMED Stock Against Markets
CONMED Corporate Directors
| John Workman | Independent Director | Profile | |
| Charles Farkas | Independent Director | Profile | |
| Jerome Lande | Independent Director | Profile | |
| David Bronson | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CONMED. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.028 | Dividend Share 0.8 | Earnings Share 4.25 | Revenue Per Share | Quarterly Revenue Growth 0.058 |
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.